INCOME STATEMENT (Annual GAAP In millions $) |
(Dec 31 2022) 2022 |
(Dec 31 2021) 2021 |
(Dec 31 2020) 2020 |
(Dec 31 2019) 2019 |
(Dec 31 2018) 2018 |
Revenue From Contract With Customer Excluding Assessed Tax |
460.71 |
464.48 |
406.56 |
459.96 |
453.04 |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
- |
- |
- |
Revenue From Product Sales |
- |
- |
- |
- |
- |
Market Service Revenue |
- |
- |
- |
- |
- |
Other Revenue |
0.00 |
- |
- |
0.00 |
- |
Total Revenue |
460.71 |
464.48 |
406.56 |
459.96 |
453.04 |
Cost of Goods and Services Sold |
123.54 |
114.91 |
101.89 |
100.61 |
96.63 |
Gross
Profit |
337.17 |
349.57 |
304.67 |
359.35 |
356.41 |
Selling, Administration, Marketing |
228.81 |
290.67 |
272.38 |
309.28 |
290.03 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
49.07 |
49.62 |
39.06 |
34.64 |
33.22 |
(Gain) Loss Related to Litigation Settlement |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
72.56 |
- |
0.00 |
- |
0.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability |
- |
- |
- |
- |
3.07 |
Acquisition Related Amortization And Remeasurement |
- |
17.59 |
-0.50 |
34.21 |
- |
Total operating costs including COS |
473.98 |
472.79 |
412.83 |
478.74 |
422.95 |
Operating income/-loss
|
-13.27 |
-8.32 |
-6.27 |
-18.78 |
30.09 |
Other Deductions / - Income |
Interest expense |
1.29 |
1.84 |
2.48 |
0.12 |
0.83 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
1.29 |
1.84 |
-2.48 |
0.12 |
0.83 |
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
3.15 |
3.34 |
-8.38 |
8.14 |
6.38 |
Total costs & expenses |
478.42 |
477.97 |
406.93 |
487.00 |
430.16 |
Income /-loss before income taxes |
-17.71 |
-13.50 |
-0.37 |
-27.05 |
22.89 |
Income taxes expenses/-benefit |
2.04 |
24.88 |
-2.89 |
1.41 |
9.07 |
Income after income taxes |
-19.75 |
-38.38 |
2.52 |
-28.46 |
13.81 |
Net income/-loss
of other equity |
- |
- |
- |
- |
0.00 |
Income/-loss
from cont. Ops. |
-19.75 |
-38.38 |
2.52 |
-28.46 |
13.81 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Income Loss From Discontinued Operations Before Tax |
- |
- |
- |
- |
- |
Gain Loss From Discontinued Operations Before Income Tax |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-19.75 |
-38.38 |
2.52 |
-28.46 |
13.81 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-19.75 |
-38.38 |
2.52 |
-28.46 |
13.81 |
EBIT |
-16.42 |
-11.66 |
-2.85 |
-26.93 |
23.71 |
EBITD |
12.60 |
17.94 |
27.70 |
-2.23 |
42.37 |
EBITDA |
12.60 |
17.94 |
27.70 |
-2.23 |
42.37 |